KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
This report looks at the implications of new financial reporting standards for Chinese companies, particularly in areas relating to systems, processes and people.
This report is only available in Chinese. Please view the Chinese page for details.
Tax and Regulatory Issues - Rules and regulation often change as industries evolve. This publication keeps you updated on regulatory and compliance issues in China.
Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.